The United States-Mexico-Canada Agreement keeps drug prices high but could potentially spur new research opportunities, a pharmaceutical expert told Healio Family Medicine.
The agreement between the three countries announced on Nov. 30, but still subject to approval by Congress and legislatures in Canada and Mexico, will significantly change how the U.S. does business with some of its closest geographic neighbors, members of President Donald J. Trump’s administration said.
Search Healio's robust listing of national and international medical meetings.
Tell us what you think about Healio.com »
Get the latest news and education delivered to your inbox
©2018 Healio All Rights Reserved.